Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion.

Source:http://linkedlifedata.com/resource/pubmed/id/18850012

Download in:

View as

General Info

PMID
18850012